← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 2, 2020Last known activity
Feb 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Recent trials (11)
- NCT06478758Lead sponsorPhase 4Feb 1, 2024
- NCT06478758OfficialPhase 4Feb 1, 2024
- NCT06865300Lead sponsorN/AJul 1, 2023
- NCT06865300Sponsor investigatorN/AJul 1, 2023
- NCT06865300OfficialN/AJul 1, 2023
- NCT06579339Lead sponsorN/AMay 5, 2023
- NCT06070480Reponsible party - principal investigatorN/AJan 5, 2022
- NCT06070480Overall official - principal investigatorN/AJan 5, 2022
- NCT06070480Lead sponsorN/AJan 5, 2022
- NCT05937711Lead sponsorN/ANov 2, 2020
- NCT05937711Sponsor investigatorN/ANov 2, 2020
Details
- Last known activity
- Feb 1, 2024